3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Other solid neoplasm
1
Genitourinary
1
Gastrointestinal
1
CNS
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
21
Leukemia, Myeloid, Acute
20
Lymphoma, Non-Hodgkin
19
Hodgkin Disease
18
Multiple Myeloma
17
Myelodysplastic Syndromes
16
Lymphoma
16
Graft vs Host Disease
16
Lymphoma, Mantle-Cell
15
Leukemia, Lymphocytic, Chronic, B-Cell
15
Leukemia
14
Sarcoma
11
Lymphoma, Large B-Cell, Diffuse
11
Lymphoma, Follicular
11
Glioblastoma
11
Tuberous Sclerosis
10
Lymphoma, B-Cell, Marginal Zone
10
Carcinoma, Renal Cell
10
Neoplasms
9
Hematologic Neoplasms
9
Gliosarcoma
9
Carcinoma, Hepatocellular
9
Breast Neoplasms
9
Brain Neoplasms
9
Waldenstrom Macroglobulinemia
8
Myeloproliferative Disorders
8
Melanoma
8
Burkitt Lymphoma
8
Recurrence
7
Neoplasm Metastasis
7
Interventions
Carboplatin
4
Cisplatin
3
sodium thiosulfate
2
Vincristine
2
Granulocyte Colony-Stimulating Factor
2
Gene Expression Profiling
2
Etoposide
2
Cyclophosphamide
2
tazemetostat
1
sonidegib
1
regorafenib
1
pegylated granulocyte colony-stimulating factor
1
palbociclib
1
olaparib
1
etoposide phosphate
1
cixutumumab
1
X-Rays
1
Vemurafenib
1
Ursodeoxycholic Acid
1
Topotecan
1
Thiotepa
1
Specimen Handling
1
Sirolimus
1
Simvastatin
1
Restraint, Physical
1
Radiation
1
Psychiatric Rehabilitation
1
Polymerase Chain Reaction
1
Phantoms, Imaging
1
Peripheral Blood Stem Cell Transplantation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Hepatoblastoma
×
Sirolimus
×
Clear all
NCT01331135
2020-05-29
Aflac ST0901
Emory University
Phase 1
Completed
18 enrolled